NTRK1 and overgrowth syndrome: A dysfunction in the receptor tyrosine kinase (RTK)/PI3K/AKT pathway that specifically promotes a rapid increase in insulin receptor expression is most likely the pathophysiological basis of some overgrowth syndromes [4].